depression

News

Digital health app Juli shows worth in asthma, depression

Juli, an artificial intelligence-powered platform to help people manage chronic health conditions, has been shown to improve outcomes in a pair of randomised clinical tria

News

Big Health buys teen depression DTx developer Limbix

In another example of consolidation in the digital therapeutics (DTx) category, Big Health has agreed to buy Limbix, adding its app for adolescents and young adults with s

News

Study shows psilocybin offers cost-effective solution for ma...

Psilocybin, a psychedelic compound found in certain mushrooms, could offer a more cost-effective treatment option for major depressive disorder than current methods, according to rese

News

Biomarker study raises hope of better depression therapies

Researchers may have identified imaging-based biomarkers that could be used to identify different subtypes of major depressive disorder (MDD) and potentially lead to the d

R&D

One size does not fit all: Why a shift is needed in how we t...

Two of the biggest advances in healthcare in the last decade have been the gradual de-stigmatisation of mental health and the increased interest in researching the causes and treatments of

News

Digital depression, anxiety therapies backed for NHS use

NICE has followed through on plans to make a series of digital therapeutics (DTx) for adults with anxiety disorders or depression in England, although it acknowledges more

Digital health app Juli shows worth in asthma, depression

Big Health buys teen depression DTx developer Limbix

Study shows psilocybin offers cost-effective solution for ma...

Biomarker study raises hope of better depression therapies

One size does not fit all: Why a shift is needed in how we t...

Digital depression, anxiety therapies backed for NHS use

CDMOs: Their crucial role and how to select one, with Sigma ...

How to meet your physicians where they are online

depression

Editor's Picks